A monoclonal antibody drug developed against COVID-19 is likely to be more effective than repurposed medicines currently being tested against the virus. Skovronsky said the therapies - which may also be used to prevent the disease - could beat a vaccine to widespread use as a COVID-19 treatment, if they prove effective. We have limited manufacturing capacity. The better solution is to widely inoculate people with COVID-19 vaccines when available, and reserve antibody treatments for people who have the disease or were recently exposed to it. Lilly hopes to conduct a COVID-19 prevention clinical trial in nursing home patients later this year, he added.

Source: bd News24 June 11, 2020 02:37 UTC